TITLE

HERBAL PRODUCTS BEGIN TO ATTRACT THE ATTENTION OF BRAND-NAME DRUG COMPANIES

AUTHOR(S)
Cottrell, Kate
PUB. DATE
July 1996
SOURCE
CMAJ: Canadian Medical Association Journal;7/15/1996, Vol. 155 Issue 2, p216
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35492889

 

Related Articles

  • The Premarin predicament. Pascoe, Elaine // Practical Horseman;Apr99, Vol. 27 Issue 4, p52 

    Discusses the controversy surrounding Premarin, a brand-name drug extracted from pregnant mares' urine used as a hormone-replacement therapy for menopausal women. Benefits of estrogen; Information on hormone-replacement therapy; Availability of other estrogen products; Information on herbal and...

  • Mainstream drug companies marketing herbal remedies.  // NCRHI Newsletter;Sep/Oct98, Vol. 21 Issue 5, p3 

    States that well-known drug manufacturers in the United States are producing herbal products. Information on the herbal products manufactured by the companies; Precautionary measures released by the government regarding these herbal products.

  • The other drug war here at home.  // U.S. News & World Report;9/11/89, Vol. 107 Issue 10, p11 

    Discusses the battle between brand-name pharmaceutical companies and the generic-drug industry. Food and Drug Administration probe into generic-drug products; Scandal; Costs.

  • These 'savings' might cost you more.  // Consumer Reports Money Adviser;Jul2012, Vol. 9 Issue 7, p4 

    The article presents information on promotions by brand-name drug companies which may not be cost-effective for consumers. Tips are presented on offers for prescription medication which may be misleading, including coupons issued by drug manufacturers, free drug samples of brand-name products,...

  • Sutent [sunitinib malate].  // Pharmaceutical Executive;Dec2005, Vol. 25 Issue 12, p62 

    The article presents information about the drug Sutent (sunitinib malate) from Pfizer Inc. Sutent is a targeted therapy that possesses significant anti-angiogenic properties. It checks the growth of tumors by slowing the production of new blood-vessels. In addition to its strong clinical data,...

  • Generics makers fight brand-name competition from "authorized" drugs. Wechsler, Jill // Managed Healthcare Executive;Sep2006, Vol. 16 Issue 9, p10 

    The article reports on the competition between generic drug makers and brand-name firms who are putting out their own authorized generic products. This move by the brand-name companies undercuts the innovator's price but it hurts the generics firms by reducing the value of the 180-day...

  • Permission Granted. Reznick, Robert P.; Kobak Jr., James B. // Pharmaceutical Executive;May2004, Vol. 24 Issue 5, p50 

    Focuses on the legal aspects of authorized generic drugs, products that are copies of the brand-name products of pharmaceutical industry in the U.S. Provisions of the Hatch-Waxman Act that allow brand-name companies to enjoy revenues intended to increase competition; Generic copies of brand-name...

  • Certain Drugs May Interfere With Proper Exercise.  // Nutrition Health Review: The Consumer's Medical Journal;2005, Issue 93, p15 

    The article reports that many commonly used pharmaceuticals including prescription agents, over-the-counter drugs and herbal products can affect the response to exercise, potentially increasing the risk of injury. Herbal teas may also contain compounds that can elevate the heart rate. Dietary...

  • The big lie about generic drugs.  // Consumer Reports;Aug87, Vol. 52 Issue 8, p480 

    Discussion of the generic drug and prescription drug competition. Most generic drugs are manufactured by the same companies that make the brand-name drugs. The innovator companies get higher prices for the name brand products without any change in the product's quality. INSET: Pharmaceutical...

  • GENRICS: The benefits and challenges. STEWART, PORTIA A. // Firstline;May2011, Vol. 7 Issue 5, p30 

    The article provides information about generic drugs to allow teams in a veterinary practice to make informed decisions about how to best serve clients and patients. Generic drugs are less-expensive bioequivalent substitutes to brand-name products manufactured by another company after the patent...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics